Health
COVID-19 mortality odds lower for metformin users with diabetes – Healio
Prior use of metformin was associated with a threefold decrease in COVID-19 mortality for people with diabetes independent of glucose profile and BMI, according…
Prior use of metformin was associated with a threefold decrease in COVID-19 mortality for people with diabetes independent of glucose profile and BMI, according to study data.
“It was a surprise to us to see such a significant decrease in mortality linked to prior use of metformin, even after all of the adjustments, and to find that these beneficial effects were not linked to any improvement in glycemic control or obesity — blood glucose, HbA1c or BMI were not lower in COVID-19 survivors,” Anath…
-
Business20 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News16 hours agoWilliam Robinson dies aged 89
-
Business21 hours agoWhat to do with these 3 ASX 200 retail shares after strong price runs: experts
-
General16 hours agoCalls for corruption probe into completion of mayor’s Surfers Paradise Bowls Club site purchase